{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T06:27:48Z","timestamp":1794637668803,"version":"4.9.1"},"reference-count":115,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antioxidants"],"abstract":"<jats:p>Down syndrome (DS), the most common human aneuploidy, is associated with oxidative stress, which contributes to morphological abnormalities, immune dysfunction, cognitive impairment and accelerated ageing. This article aims to provide an overview of the studies on oxidative stress in DS, in particular the investigation of endogenous and exogenous antioxidants, with a focus on endogenous systems. A literature search in MEDLINE and Scopus based on the PRISMA 2020 criteria revealed 41 relevant studies that mainly analysed blood samples (plasma or serum) and occasionally saliva or urine. The findings suggest that oxidative stress in DS is multifactorial and results from an imbalance of superoxide dismutase activity, overexpression of genes on chromosome 21, mitochondrial dysfunction and inflammation. Despite extensive studies over the decades, new sources and mechanisms for oxidative stress in DS continue to emerge, further highlighting the complexity of DS. The recognition that oxidative stress is a hallmark of DS emphasises the need to develop more sensitive and specific methods to detect it and to investigate the associated metabolic pathways in DS in more detail. The expansion of in vivo studies could facilitate the development of targeted interventions aimed at mitigating oxidative damage and ultimately improving outcomes for individuals with DS.<\/jats:p>","DOI":"10.3390\/antiox14070816","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T09:08:44Z","timestamp":1751447324000},"page":"816","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Oxidative Stress and Down Syndrome: A Systematic Review"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7978-739X","authenticated-orcid":false,"given":"Goran","family":"Sliv\u0161ek","sequence":"first","affiliation":[{"name":"Institute for Anthropological Research, Gajeva ulica 32, 10000 Zagreb, Croatia"},{"name":"Faculty of Medicine, University of Zagreb, \u0160alata 3, 10000 Zagreb, Croatia"},{"name":"Faculty of Medicine, University of Rijeka, Ulica Bra\u0107e Branchetta 20, 51000 Rijeka, Croatia"},{"name":"Faculty of Pharmacy and Biochemistry, University of Zagreb, Ulica Ante Kova\u010di\u0107a 1, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Mija\u010d","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Zagreb, \u0160alata 3, 10000 Zagreb, Croatia"},{"name":"Faculty of Pharmacy and Biochemistry, University of Zagreb, Ulica Ante Kova\u010di\u0107a 1, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6452-8080","authenticated-orcid":false,"given":"Ivan","family":"Dolanc","sequence":"additional","affiliation":[{"name":"Institute for Anthropological Research, Gajeva ulica 32, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marija","family":"Fabijanec","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy and Biochemistry, University of Zagreb, Ulica Ante Kova\u010di\u0107a 1, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvija","family":"Petkovi\u0107","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Rijeka, Ulica Bra\u0107e Branchetta 20, 51000 Rijeka, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Mautner","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Zagreb, \u0160alata 3, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2481-5098","authenticated-orcid":false,"given":"Karmen","family":"Lon\u010darek","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Rijeka, Ulica Bra\u0107e Branchetta 20, 51000 Rijeka, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josip","family":"Kranj\u010di\u0107","sequence":"additional","affiliation":[{"name":"School of Dental Medicine, University of Zagreb, Gunduli\u0107eva 5, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alenka Boban","family":"Blagai\u0107","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Zagreb, \u0160alata 3, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7271-9434","authenticated-orcid":false,"given":"Marin","family":"Marinovi\u0107","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Rijeka, Ulica Bra\u0107e Branchetta 20, 51000 Rijeka, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9842-8122","authenticated-orcid":false,"given":"Ksenija","family":"Vitale","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Zagreb, \u0160alata 3, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9106-1604","authenticated-orcid":false,"given":"Donatella","family":"Verbanac","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy and Biochemistry, University of Zagreb, Ulica Ante Kova\u010di\u0107a 1, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miran","family":"\u010coklo","sequence":"additional","affiliation":[{"name":"Institute for Anthropological Research, Gajeva ulica 32, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6365-5686","authenticated-orcid":false,"given":"Jadranka","family":"Vranekovi\u0107","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Rijeka, Ulica Bra\u0107e Branchetta 20, 51000 Rijeka, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10522-006-9002-5","article-title":"Multiple Evidence for An Early Age Pro-Oxidant State in Down Syndrome Patients","volume":"7","author":"Degan","year":"2006","journal-title":"Biogerontology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41572-019-0143-7","article-title":"Down Syndrome","volume":"6","author":"Antonarakis","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1002\/ajmg.a.61636","article-title":"The Burden of Chronic Disease, Multimorbidity, and Polypharmacy in Adults with Down Syndrome","volume":"182","author":"Romano","year":"2020","journal-title":"Am. J. Med. Genet. Part A"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Rueda Revilla, N., and Mart\u00ednez-Cu\u00e9, C. (2020). Antioxidants in Down Syndrome: From Preclinical Studies to Clinical Trials. Antioxidants, 9.","DOI":"10.3390\/antiox9080692"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"6937154","DOI":"10.1155\/2020\/6937154","article-title":"Neuroinflammatory Markers in the Serum of Prepubertal Children with Down Syndrome","volume":"2020","author":"Tarani","year":"2020","journal-title":"J. Immunol. Res."},{"key":"ref_6","first-page":"12","article-title":"Methyltetrahydrofolate-Homocysteine Methyltransferase Reductase Gene and Congenital Heart Defects in Down Syndrome","volume":"4","year":"2020","journal-title":"Genet. Appl."},{"key":"ref_7","first-page":"535","article-title":"Oxidative Stress and Down Syndrome. Do Antioxidants Play a Role in Therapy?","volume":"63","year":"2014","journal-title":"Physiol. Res."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Kuhn, E., Natacci, F., Corbo, M., Pisani, L., Ferrero, S., Bulfamante, G., and Gambini, D. (2023). The Contribution of Oxidative Stress to NF1-Altered Tumors. Antioxidants, 12.","DOI":"10.3390\/antiox12081557"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Mladenov, M., Lubomirov, L., Grisk, O., Avtanski, D., Mitrokhin, V., Sazdova, I., Keremidarska-Markova, M., Danailova, Y., Nikolaev, G., and Konakchieva, R. (2023). Oxidative Stress, Reductive Stress and Antioxidants in Vascular Pathogenesis and Aging. Antioxidants, 12.","DOI":"10.3390\/antiox12051126"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Di Carlo, E., and Sorrentino, C. (2024). Oxidative Stress and Age-Related Tumors. Antioxidants, 13.","DOI":"10.3390\/antiox13091109"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Du, Y., Chai, Y., Zheng, X., and Zheng, Y. (2023). Theoretical Study on the Multiple Free Radical Scavenging Reactions of Pyranoanthocyanins. Antioxidants, 13.","DOI":"10.3390\/antiox13010033"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.cbi.2014.10.016","article-title":"Free Radicals, Reactive Oxygen Species, Oxidative Stress and Its Classification","volume":"224","author":"Lushchak","year":"2014","journal-title":"Chem. Biol. Interact."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Kozlov, A.V., Javadov, S., and Sommer, N. (2024). Cellular ROS and Antioxidants: Physiological and Pathological Role. Antioxidants, 13.","DOI":"10.3390\/antiox13050602"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"C849","DOI":"10.1152\/ajpcell.00283.2008","article-title":"Radical-Free Biology of Oxidative Stress","volume":"295","author":"Jones","year":"2008","journal-title":"Am. J. Physiol. Physiol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Plascencia-Villa, G., and Perry, G. (2023). Roles of Oxidative Stress in Synaptic Dysfunction and Neuronal Cell Death in Alzheimer\u2019s Disease. Antioxidants, 12.","DOI":"10.3390\/antiox12081628"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.neurobiolaging.2006.03.008","article-title":"Oxidative Stress: A Bridge between Down\u2019s Syndrome and Alzheimer\u2019s Disease","volume":"28","author":"Zana","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e12812","DOI":"10.1111\/acel.12812","article-title":"Nrf2 Stabilization Prevents Critical Oxidative Damage in Down Syndrome Cells","volume":"17","author":"Zamponi","year":"2018","journal-title":"Aging Cell"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1139\/cjpp-2018-0604","article-title":"Molecular Hydrogen: Potential in Mitigating Oxidative-Stress-Induced Radiation Injury","volume":"97","author":"Kura","year":"2019","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1007\/s10571-023-01417-6","article-title":"The Role of Oxidative Stress in Trisomy 21 Phenotype","volume":"43","author":"Sidorkiewicz","year":"2023","journal-title":"Cell. Mol. Neurobiol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Berd\u00fan, R., Obis, \u00c8., Mota-Martorell, N., Bassols, A., Valent, D., Serrano, J.C.E., Mart\u00edn-Gar\u00ed, M., Rodr\u00edguez-Palmero, M., Moreno-Mu\u00f1oz, J.A., and Tibau, J. (2024). High-Fat Diet-Induced Obesity Increases Brain Mitochondrial Complex I and Lipoxidation-Derived Protein Damage. Antioxidants, 13.","DOI":"10.3390\/antiox13020161"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1152\/physrev.00040.2012","article-title":"Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases","volume":"94","author":"Bhattacharyya","year":"2014","journal-title":"Physiol. Rev."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1159\/000485089","article-title":"Antioxidants Maintain Cellular Redox Homeostasis by Elimination of Reactive Oxygen Species","volume":"44","author":"He","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Jin, S., and Kang, P.M. (2024). A Systematic Review on Advances in Management of Oxidative Stress-Associated Cardiovascular Diseases. Antioxidants, 13.","DOI":"10.3390\/antiox13080923"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Juan, C.A., P\u00e9rez de la Lastra, J.M., Plou, F.J., and P\u00e9rez-Lebe\u00f1a, E. (2021). The Chemistry of Reactive Oxygen Species (ROS) Revisited: Outlining Their Role in Biological Macromolecules (DNA, Lipids and Proteins) and Induced Pathologies. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094642"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1152\/physrev.00029.2006","article-title":"Nitric Oxide and Peroxynitrite in Health and Disease","volume":"87","author":"Pacher","year":"2007","journal-title":"Physiol. Rev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"5839","DOI":"10.1073\/pnas.1804932115","article-title":"Oxygen Radicals, Nitric Oxide, and Peroxynitrite: Redox Pathways in Molecular Medicine","volume":"115","author":"Radi","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Hur, J., Sullivan, K.A., Schuyler, A.D., Hong, Y., Pande, M., States, D.J., Jagadish, H.V., and Feldman, E.L. (2010). Literature-Based Discovery of Diabetes- and ROS-Related Targets. BMC Med. Genom., 3.","DOI":"10.1186\/1755-8794-3-49"},{"key":"ref_28","first-page":"124","article-title":"Reactive Oxygen Species\u2014Sources, Functions, Oxidative Damage","volume":"48","author":"Jakubczyk","year":"2020","journal-title":"Pol. Merkur. Lek. Organ Pol. Tow. Lek."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"471","DOI":"10.18632\/aging.100189","article-title":"P53, ROS and Senescence in the Control of Aging","volume":"2","author":"Vigneron","year":"2010","journal-title":"Aging"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"199.e1","DOI":"10.1016\/j.neurobiolaging.2010.06.018","article-title":"Aluminum Induces Neurodegeneration and Its Toxicity Arises from Increased Iron Accumulation and Reactive Oxygen Species (ROS) Production","volume":"33","author":"Wu","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Halliwell, B., and Gutteridge, J.M.C. (2015). Free Radicals in Biology and Medicine, Oxford University Press. [5th ed.].","DOI":"10.1093\/acprof:oso\/9780198717478.001.0001"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ejmech.2015.04.040","article-title":"The Role of Antioxidants in the Chemistry of Oxidative Stress: A Review","volume":"97","author":"Pisoschi","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/WOX.0b013e3182439613","article-title":"Oxidative Stress and Antioxidant Defense","volume":"5","author":"Birben","year":"2012","journal-title":"World Allergy Organ. J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"238","DOI":"10.4103\/1673-5374.244780","article-title":"Oxidative Stress: The Lowest Common Denominator of Multiple Diseases","volume":"14","author":"Matschke","year":"2019","journal-title":"Neural Regen. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.ejmech.2019.06.010","article-title":"Medicinal Prospects of Antioxidants: A Review","volume":"178","author":"Neha","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/oxfordjournals.bmb.a072625","article-title":"An Introduction to Free Radical Biochemistry","volume":"49","author":"Cheeseman","year":"1993","journal-title":"Br. Med. Bull."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Morales-Gonzalez, J.A., Morales-Gonzalez, A., and Madrigal-Santillan, E.O. (2016). A Master Regulator of Oxidative Stress\u2014The Transcription Factor Nrf2, InTech.","DOI":"10.5772\/62743"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jconrel.2006.04.015","article-title":"Role of Antioxidants in Prophylaxis and Therapy: A Pharmaceutical Perspective","volume":"113","author":"Ratnam","year":"2006","journal-title":"J. Control. Release"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"8416763","DOI":"10.1155\/2017\/8416763","article-title":"Oxidative Stress: Harms and Benefits for Human Health","volume":"2017","author":"Pizzino","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1089\/ars.2015.6317","article-title":"Clinical Relevance of Biomarkers of Oxidative Stress","volume":"23","author":"Frijhoff","year":"2015","journal-title":"Antioxid. Redox Signal."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"6501046","DOI":"10.1155\/2017\/6501046","article-title":"Measurement and Clinical Significance of Biomarkers of Oxidative Stress in Humans","volume":"2017","author":"Marrocco","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Juranek, J.K., Daffu, G.K., Wojtkiewicz, J., Lacomis, D., Kofler, J., and Schmidt, A.M. (2015). Receptor for Advanced Glycation End Products and Its Inflammatory Ligands Are Upregulated in Amyotrophic Lateral Sclerosis. Front. Cell. Neurosci., 9.","DOI":"10.3389\/fncel.2015.00485"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"381","DOI":"10.14639\/0392-100X-897","article-title":"Advanced Oxidation Protein Product Levels as a Marker of Oxidative Stress in Paediatric Patients with Chronic Tonsillitis","volume":"36","author":"Ozbay","year":"2016","journal-title":"Acta Otorhinolaryngol. Ital."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1084\/jem.137.2.317","article-title":"The Linkage of Genes for the Human Interferon-Induced Antiviral Protein and Indophenol Oxidase-B Traits to Chromosome G-21","volume":"137","author":"Tan","year":"1973","journal-title":"J. Exp. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s10522-010-9269-4","article-title":"Mitochondrial Dysfunction in Some Oxidative Stress-Related Genetic Diseases: Ataxia-Telangiectasia, Down Syndrome, Fanconi Anaemia and Werner Syndrome","volume":"11","author":"Lloret","year":"2010","journal-title":"Biogerontology"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.lfs.2013.08.017","article-title":"Systemic Oxidative Stress in Children and Teenagers with Down Syndrome","volume":"93","author":"Garlet","year":"2013","journal-title":"Life Sci."},{"key":"ref_47","first-page":"53","article-title":"Evaluation of Oxidant\/Antioxidant System, IL-6 and IL-10 Parameters and SOD-Enzyme Activity in Pregnancy with Down Syndrome in Amnion Fluid Analysis","volume":"33","author":"Bahsi","year":"2022","journal-title":"Gazi Med. J."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2310\/6650.2001.34089","article-title":"Superoxide Dismutase SOD1, Encoded on Chromosome 21, but Not SOD2 Is Overexpressed in Brains of Patients with down Syndrome","volume":"49","author":"Gulesserian","year":"2001","journal-title":"J. Investig. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1046\/j.1471-4159.2001.00107.x","article-title":"Effect of Overexpression of Wild-type and Mutant Cu\/Zn-Superoxide Dismutases on Oxidative Damage and Antioxidant Defences: Relevance to Down\u2019s Syndrome and Familial Amyotrophic Lateral Sclerosis","volume":"76","author":"Lee","year":"2001","journal-title":"J. Neurochem."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Lubec, G. (2003). Advances in Down Syndrome Research, Springer.","DOI":"10.1007\/978-3-7091-6721-2"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.pnpbp.2006.07.010","article-title":"Omega-3 Fatty Acids and Antioxidants in Neurological and Psychiatric Diseases: An Overview","volume":"31","author":"Mazza","year":"2007","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.biopha.2015.08.007","article-title":"Evaluation of Extracellular Adenine Nucleotides Hydrolysis in Platelets and Biomarkers of Oxidative Stress in Down Syndrome Individuals","volume":"74","author":"Ferreira","year":"2015","journal-title":"Biomed. Pharmacother."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"724904","DOI":"10.1155\/2012\/724904","article-title":"Oxidative Stress and Down Syndrome: A Route toward Alzheimer-like Dementia","volume":"2012","author":"Perluigi","year":"2012","journal-title":"Curr. Gerontol. Geriatr. Res."},{"key":"ref_54","first-page":"8737649","article-title":"Overexpression of Chromosome 21 MiRNAs May Affect Mitochondrial Function in the Hearts of Down Syndrome Fetuses","volume":"2017","author":"Izzo","year":"2017","journal-title":"Int. J. Genom."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/dneu.22673","article-title":"The Shape of Mitochondrial Dysfunction in Down Syndrome","volume":"79","author":"Zamponi","year":"2019","journal-title":"Dev. Neurobiol."},{"key":"ref_56","first-page":"1","article-title":"The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews","volume":"372","author":"Page","year":"2021","journal-title":"Br. Med. J."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Higgins, J.P.T., Thomas, J., Chandler, J., Cumpst, M., Li, T., Page, M.J., and Welch, V.A. (2019). Cochrane Handbook for Systematic Reviews of Interventions, Wiley-Blackwell. [2nd ed.].","DOI":"10.1002\/9781119536604"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13643-021-01877-1","article-title":"Where to Prospectively Register a Systematic Review","volume":"11","author":"Pieper","year":"2022","journal-title":"Syst. Rev."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s Tool for Assessing Risk of Bias in Randomised Trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jid.2016.08.021","article-title":"Research Techniques Made Simple: Assessing Risk of Bias in Systematic Reviews","volume":"136","author":"Drucker","year":"2016","journal-title":"J. Investig. Dermatol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/imm.12659","article-title":"The Contribution of the Citrate Pathway to Oxidative Stress in Down Syndrome","volume":"149","author":"Convertini","year":"2016","journal-title":"Immunology"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"11","DOI":"10.12816\/0026942","article-title":"The Association between Anti\u2014Oxidant\/Redox Status and Sister Chromatid Exchanges in down Syndrome Individuals","volume":"8","author":"Sadiq","year":"2015","journal-title":"Jordan J. Biol. Sci."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s12098-012-0795-8","article-title":"Levels of Non Enzymatic Antioxidants in Down Syndrome","volume":"79","author":"Sulthana","year":"2012","journal-title":"Indian J. Pediatr."},{"key":"ref_64","first-page":"43","article-title":"Antioxidant Enzyme Activity in Children with Down Syndrome","volume":"16","author":"Sulthana","year":"2012","journal-title":"Curr. Pediatr. Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1515\/CCLM.2007.011","article-title":"Lipid Peroxidation in Down Syndrome Caused by Regular Trisomy 21, Trisomy 21 by Robertsonian Translocation and Mosaic Trisomy 21","volume":"45","author":"Casado","year":"2007","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3104\/reports.318","article-title":"Glucose-6-Phosphate-Dehydrogenase Is Also Increased in Erythrocytes from Adolescents with Down Syndrome","volume":"11","author":"Ordonez","year":"2006","journal-title":"Down Syndr. Res. Pract."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.4065\/80.12.1607","article-title":"Oxidative Stress and Hematologic and Biochemical Parameters in Individuals with Down Syndrome","volume":"80","author":"Garcez","year":"2005","journal-title":"Mayo Clin. Proc."},{"key":"ref_68","first-page":"787","article-title":"The Relationship between Antioxidant Systems and Some Markers of Oxidative Stress in Persons with Down Syndrome","volume":"59","author":"Pueschel","year":"2004","journal-title":"Biologia"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cccn.2003.11.020","article-title":"Uric Acid and Allantoin Levels in Down Syndrome: Antioxidant and Oxidative Stress Mechanisms?","volume":"341","author":"Aruoma","year":"2004","journal-title":"Clin. Chim. Acta"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1067\/mpd.2003.203","article-title":"Glutathione Metabolism and Antioxidant Enzymes in Children with Down Syndrome","volume":"142","author":"Pastore","year":"2003","journal-title":"J. Pediatr."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1086\/321262","article-title":"Homocysteine Metabolism in Children with Down Syndrome: In Vitro Modulation","volume":"69","author":"Pogribna","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1385\/BTER:78:1-3:35","article-title":"Thyroid Hypofunction in Down\u2019s Syndrome: Is It Related to Oxidative Stress?","volume":"78","author":"Kanavin","year":"2000","journal-title":"Biol. Trace Elem. Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/S0006-3223(99)00026-8","article-title":"Correlations of Glutathione Peroxidase Activity with Memory Impairment in Adults with Down Syndrome","volume":"46","author":"Brugge","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/clinchem\/44.5.924","article-title":"Antioxidant Enzymes and Fatty Acid Status in Erythrocytes of Down Syndrome Patients","volume":"44","author":"Pastor","year":"1998","journal-title":"Clin. Chem."},{"key":"ref_75","first-page":"272","article-title":"Erythrocyte Antioxidant System in Down Syndrome","volume":"7","author":"Gerli","year":"1990","journal-title":"Am. J. Med. Genet. Suppl."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3109\/13816818909009882","article-title":"Oxidative Stress in Trisomy 21: A Possible Role in Cataractogenesis","volume":"10","author":"Monteiro","year":"1989","journal-title":"Ophthalmic Paediatr. Genet."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Lazzarino, G., Amorini, A.M., Mangione, R., Saab, M.W., Di Stasio, E., Di Rosa, M., Tavazzi, B., Lazzarino, G., Onder, G., and Carf\u00ec, A. (2022). Biochemical Discrimination of the Down Syndrome-Related Metabolic and Oxidative\/Nitrosative Stress Alterations from the Physiologic Age-Related Changes through the Targeted Metabolomic Analysis of Serum. Antioxidants, 11.","DOI":"10.3390\/antiox11061208"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1080\/10715762.2016.1253833","article-title":"Increased Non-Protein Bound Iron in Down Syndrome: Contribution to Lipid Peroxidation and Cognitive Decline","volume":"50","author":"Manna","year":"2016","journal-title":"Free Radic. Res."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Buczy\u0144ska, A., Sidorkiewicz, I., \u0141awicki, S., Kr\u0119towski, A.J., and Zbucka-Kr\u0119towska, M. (2021). Prenatal Screening of Trisomy 21: Could Oxidative Stress Markers Play a Role?. J. Clin. Med., 10.","DOI":"10.3390\/jcm10112382"},{"key":"ref_80","first-page":"306","article-title":"Markers of Oxidative Stress in Children with Down Syndrome","volume":"44","author":"Pueschel","year":"2006","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3104\/reports.134","article-title":"Oxidative Stress in Portuguese Children with Down Syndrome","volume":"8","author":"Pinto","year":"2002","journal-title":"Down Syndr. Res. Pract."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/scd.12258","article-title":"Reduced Salivary Flow Rate and High Levels of Oxidative Stress in Whole Saliva of Children with Down Syndrome","volume":"37","author":"Domingues","year":"2017","journal-title":"Spec. Care Dent."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.archoralbio.2014.09.013","article-title":"Antioxidants and Biomarkers of Oxidative Damage in the Saliva of Patients with Down\u2019s Syndrome","volume":"60","author":"Vieira","year":"2015","journal-title":"Arch. Oral Biol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/scd.12054","article-title":"Assessment of Salivary Total Antioxidant Levels and Oral Health Status in Children with Down Syndrome","volume":"34","author":"Subramaniam","year":"2014","journal-title":"Spec. Care Dent."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.archoralbio.2013.03.017","article-title":"Increased Oxidative Stress Biomarkers in the Saliva of Down Syndrome Patients","volume":"58","author":"Komatsu","year":"2013","journal-title":"Arch. Oral Biol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.annepidem.2012.09.005","article-title":"Systemic Oxidative Stress, as Measured by Urinary Allantoin and F(2)-Isoprostanes, Is Not Increased in Down Syndrome","volume":"22","author":"Tolun","year":"2012","journal-title":"Ann. Epidemiol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.lfs.2011.08.006","article-title":"Evaluation of Urinary Biomarkers of Oxidative\/Nitrosative Stress in Children with Down Syndrome","volume":"89","author":"Campos","year":"2011","journal-title":"Life Sci."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.bbadis.2011.03.013","article-title":"Evaluation of Urinary Biomarkers of Oxidative\/Nitrosative Stress in Adolescents and Adults with Down Syndrome","volume":"1812","author":"Campos","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.clinbiochem.2009.09.017","article-title":"Urinary Uric Acid and Antioxidant Capacity in Children and Adults with Down Syndrome","volume":"43","author":"Campos","year":"2010","journal-title":"Clin. Biochem."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/S0891-5849(98)00137-3","article-title":"Biomarkers of Oxidative Stress Are Significantly Elevated in Down Syndrome","volume":"25","author":"Jovanovic","year":"1998","journal-title":"Free Radic. Biol. Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/prca.201000121","article-title":"Oxidative Stress Occurs Early in Down Syndrome Pregnancy: A Redox Proteomics Analysis of Amniotic Fluid","volume":"5","author":"Perluigi","year":"2011","journal-title":"Proteom. Clin. Appl."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.clinbiochem.2006.10.019","article-title":"Early Oxidative Stress in Amniotic Fluid of Pregnancies with Down Syndrome","volume":"40","author":"Perrone","year":"2007","journal-title":"Clin. Biochem."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1096\/fba.2021-00086","article-title":"Dopamine-Related Oxidative Stress and Mitochondrial Dysfunction in Dopaminergic Neurons Differentiated from Deciduous Teeth-Derived Stem Cells of Children with Down Syndrome","volume":"4","author":"Sun","year":"2022","journal-title":"FASEB BioAdv."},{"key":"ref_94","first-page":"509241","article-title":"Intracellular Oxidant Activity, Antioxidant Enzyme Defense System, and Cell Senescence in Fibroblasts with Trisomy 21","volume":"2015","author":"Vilches","year":"2015","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1006\/bbrc.1998.8186","article-title":"Early Glycoxidation Damage in Brains from Down\u2019s Syndrome","volume":"243","author":"Odetti","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1469-8749.2000.tb00072.x","article-title":"Nutritional Supplementation in Down Syndrome: Theoretical Considerations and Current Status","volume":"42","author":"Ani","year":"2000","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1590\/S0100-40422007000500046","article-title":"Esp\u00e9cies Reativas de Oxig\u00eanio e de Nitrog\u00eanio, Antioxidantes e Marcadores de Dano Oxidativo Em Sangue Humano: Principais M\u00e9todos Anal\u00edticos Para Sua Determina\u00e7\u00e3o","volume":"30","author":"Vasconcelos","year":"2007","journal-title":"Quim. Nova"},{"key":"ref_98","unstructured":"Michelson, A.M., McCord, J.M., and Fridovich, I. (1977). Superoxide and Superoxide Dismutases, Academic Press."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0024-3205(79)90276-5","article-title":"Trisomy 21 (Down\u2019s Syndrome) Glutathione Peroxidase, Hexose Monophosphate Shunt and I.Q","volume":"24","author":"Sinet","year":"1979","journal-title":"Life Sci."},{"key":"ref_100","first-page":"70","article-title":"The Redox State of Glutathione in Erythrocytes of Individuals with Down Syndrome","volume":"108","author":"Muchova","year":"2007","journal-title":"Bratisl. Lek. Listy"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1515\/jpm-2015-0399","article-title":"Correlation between Markers of DNA and Lipid Oxidative Damage in Maternal and Fetoplacental Compartment in the Mid-Trimester of Pregnancy","volume":"45","author":"Rejc","year":"2017","journal-title":"J. Perinat. Med."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s00204-024-03696-4","article-title":"Several Lines of Antioxidant Defense against Oxidative Stress: Antioxidant Enzymes, Nanomaterials with Multiple Enzyme-Mimicking Activities, and Low-Molecular-Weight Antioxidants","volume":"98","author":"Jomova","year":"2024","journal-title":"Arch. Toxicol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0891-5849(01)00609-8","article-title":"Influence of Age on Activities of Antioxidant Enzymes and Lipid Peroxidation Products in Erythrocytes and Neutrophils of Down Syndrome Patients","volume":"31","author":"Kvasnicka","year":"2001","journal-title":"Free Radic. Biol. Med."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0165-3806(84)90060-9","article-title":"Superoxide Dismutase, Glutathione Peroxidase and Lipoperoxidation in Down\u2019s Syndrome Fetal Brain","volume":"318","author":"Brooksbank","year":"1984","journal-title":"Brain Res."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0891-5849(03)00333-2","article-title":"Urinary F2-Isoprostanes in Young Healthy Children at Risk for Type 1 Diabetes Mellitus","volume":"35","author":"Kauffman","year":"2003","journal-title":"Free Radic. Biol. Med."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2174\/092986707779941177","article-title":"Biomarkers for Oxidative Stress: Clinical Application in Pediatric Medicine","volume":"14","author":"Tsukahara","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1373\/clinchem.2005.061408","article-title":"Biomarkers of Oxidative Damage in Human Disease","volume":"52","author":"Rossi","year":"2006","journal-title":"Clin. Chem."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3109\/13547500903183954","article-title":"Comparison of Three Oxidative Stress Biomarkers in a Sample of Healthy Adults","volume":"14","author":"Watters","year":"2009","journal-title":"Biomarkers"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000452912","article-title":"Endocrine Autoimmunity in Down\u2019s Syndrome","volume":"48","author":"Guaraldi","year":"2017","journal-title":"Front. Horm. Res."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s10020-018-0004-y","article-title":"Mitochondrial Dysfunction in Down Syndrome: Molecular Mechanisms and Therapeutic Targets","volume":"24","author":"Izzo","year":"2018","journal-title":"Mol. Med."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Mosaoa, R., Kasprzyk-Pawelec, A., Fernandez, H.R., and Avantaggiati, M.L. (2021). The Mitochondrial Citrate Carrier SLC25A1\/CIC and the Fundamental Role of Citrate in Cancer, Inflammation and Beyond. Biomolecules, 11.","DOI":"10.3390\/biom11020141"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s10020-020-00225-8","article-title":"Meta-Analysis of Metabolites Involved in Bioenergetic Pathways Reveals a Pseudohypoxic State in Down Syndrome","volume":"26","author":"Pecze","year":"2020","journal-title":"Mol. Med."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"116554","DOI":"10.1016\/j.lfs.2019.116554","article-title":"Asprosin Improves the Survival of Mesenchymal Stromal Cells in Myocardial Infarction by Inhibiting Apoptosis via the Activated ERK1\/2-SOD2 Pathway","volume":"231","author":"Zhang","year":"2019","journal-title":"Life Sci."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Yuan, M., Li, W., Zhu, Y., Yu, B., and Wu, J. (2020). Asprosin: A Novel Player in Metabolic Diseases. Front. Endocrinol., 11.","DOI":"10.3389\/fendo.2020.00064"},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Lu\u00eds, C., Fernandes, R., Soares, R., and von Hafe, P. (2020). A State of the Art Review on the Novel Mediator Asprosin in the Metabolic Syndrome. Porto Biomed. J., 5.","DOI":"10.1097\/j.pbj.0000000000000108"}],"container-title":["Antioxidants"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3921\/14\/7\/816\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:03:09Z","timestamp":1760032989000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3921\/14\/7\/816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":115,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["antiox14070816"],"URL":"https:\/\/doi.org\/10.3390\/antiox14070816","relation":{},"ISSN":["2076-3921"],"issn-type":[{"value":"2076-3921","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]}}}